RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
اقرأ هذه الصفحة بـ: English · العربية · Français · Português
Countries / Nigeria
NG · NAFDAC

Nigeria

Authority
National Agency for Food and Drug Administration and Control (NAFDAC)
Legal basis
Not recorded
Address
Not recorded
Website
https://nafdac.gov.ng
Notice channel
https://nafdac.gov.ng/category/recalls-and-alerts/
The highest-volume alert channel on the continent.
Coverage
No public channel
Cadence
MOU required
On the register
0 recorded actions
Last verified
19 August 2026

Authority Channel

A named officer of NAFDAC can put a Nigeria alert on the register directly, with no review step of ours. Those records carry Tier 0 — entered and published by the issuing regulator, which is the one rank we cannot create for ourselves.

Nothing on this page carries Tier 0 today because no NAFDAC officer holds a credential yet. We issue one after confirming, out of band, that a person speaks for their authority — write to notices@drugeyeafrica.org. Notices can also be sent by email, by export, or from an existing system: how to send them.

What we monitor, and what we cannot. Blocks automated fetching. No workaround will be built: a cooperation agreement is the route in, and the relationship is worth more than the data. Cadence: MOU required. Last checked 19 August 2026.

Actions issued by NAFDAC

0 shown
No records captured yet from this authority.

Acted on elsewhere, relevant here

Cross-border
ReferenceDateCountryProductBatchesActionClassSource
DEA-BW-2024-9384184116 Apr 2024BWBenylin Paediatric 100mls Cough Syrup
Johnson & Johnson (Pty) Ltd
329304 · 329303RecallUnclassifiedTier 1 · Regulator-published

Actions by other authorities that name this market on the notice, or that belong to a cross-border event this market also appears in. An absence here is an absence of recorded links, not a statement that no such product is on this market.